Custom Transforming drug development with accurate and scalable long-read sequencing services

Date: This event took place on September 29, 2021

Custom webcast sponsor retains sole responsibility for content.

Advancements in sequencing technology have made genome scale analysis routine and accessible not only for disease investigations, but also for population scale analysis. Technologies that capture sequences as long, continuous reads have the potential to resolve many complexities in DNA and RNA samples, but have been limited in application by sequence accuracy, quality, scalability and throughput challenges.

PacBio’s Sequel II and HiFi reads address quality and accuracy issues, while HudsonAlpha Discovery’s optimized protocols and processes apply high throughput capabilities and rapid turnaround time to fully address the unmet needs of both biopharmaceutical and academic studies.

This webcast will present the advantages of HudsonAlpha Discovery’s PacBio long-read sequencing services and how they can be used to advance clinical, translational, and basic research projects spanning disease diagnostics, RNA structural variant analysis, trinucleotide repeat analysis, and population genomics.

You will learn:

  • How can researchers apply the HiFi sequencing technology in drug and diagnostic development programs at population scale?
  • What improvements are possible to CNV, indel and SNV resolution in challenging regions of the genome with long-read sequencing services?
  • How can scientists apply long-read sequencing in targeted approaches as well as RNA sequencing?

Unable to join the live event? Watch on-demand. Register now to ensure that you receive information on how to gain access after the live event.

This webcast has been produced by Discovery Life Sciences, who retains sole responsibility for content. About this content.


  • Dr. Shawn Levy, Discovery Life Sciences

    Dr. Shawn Levy, Discovery Life Sciences

    Shawn Levy, Ph.D., received his doctorate in biochemistry and completed a postdoctoral fellowship in genetics at Emory University. He is the founding director of the Genomic Services Laboratory (GSL) at the HudsonAlpha Institute for Biotechnology. Dr Levy is an expert in development and application of genomic and bioinformatic technologies to support scientific investigation.

  • Sarah Hiddleston, Science Journalist

    Moderator: Sarah Hiddleston, Science Journalist

    Sarah Hiddleston is freelance journalist working with Nature Research for Nature Middle East since 2015. Previously, Sarah worked for a decade in Madras (Chennai), India, specialising in health, pharmaceutical and environmental stories. Sarah holds an MA in Investigative Journalism from City University London, an MSc in Political Theory from the London School of Economics, and an undergraduate degree in History from the University of Cambridge, UK.